Accuray Incorporated
$ 0.24
0.08%
24 Jul - close price
- Market Cap 28,337,200 USD
- Current Price $ 0.24
- High / Low $ 0.24 / 0.23
- Stock P/E N/A
- Book Value 0.35
- EPS -0.37
- Next Earning Report 2026-08-12
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.02 %
- ROE -1.01 %
- 52 Week High 2.10
- 52 Week Low 0.23
About
Accuray Incorporated designs, develops and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa and the rest of the Asia Pacific region. The company is headquartered in Sunnyvale, California.
Analyst Target Price
$0.35
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-06 | 2026-02-04 | 2025-11-05 | 2025-08-13 | 2025-04-30 | 2025-02-05 | 2024-11-06 | 2024-08-13 | 2024-05-01 | 2024-01-31 | 2023-11-07 | 2023-08-09 |
| Reported EPS | -0.07 | -0.11 | -0.18 | 0.01 | -0.01 | 0.02 | -0.04 | 0.03 | -0.06 | -0.1 | -0.03 | -0.02 |
| Estimated EPS | -0.05 | -0.11 | -0.05 | 0.02 | -0.05 | -0.04 | -0.06 | 0.03 | -0.02 | -0.04 | -0.05 | 0.01 |
| Surprise | -0.02 | 0 | -0.13 | -0.01 | 0.04 | 0.06 | 0.02 | 0 | -0.04 | -0.06 | 0.02 | -0.03 |
| Surprise Percentage | -40% | 0% | -260% | -50% | 80% | 150% | 33.3333% | 0% | -200% | -150% | 40% | -300% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-12 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ARAY
2026-07-24 11:11:47
This article provides financial data for Accuray Incorporated (BX:XEJ), specifically its price-to-sales forward ratio. It highlights the company's financial overview within the health technology sector on BX Swiss.
2026-07-23 00:41:36
The article discusses the enterprise value to revenue forward for Accuray Incorporated (NASDAQ: ARAY). It indicates that financial information specific to this metric would be displayed, likely within a table or chart, but the content provided is primarily navigational and structural rather than data-driven. The article is hosted on TradingView, a financial platform offering various market data and analysis tools.
2026-07-23 00:41:00
This article provides the Q2 2025 earnings report for Accuray Incorporated (XEJ), detailing an EPS beat of €0.04 with actual EPS at €0.02, compared to a consensus of -€0.02. The company also surpassed revenue expectations, reporting €101.75M against an expected €96.64M, marking an 8.33% year-over-year growth. The earnings announcement took place on February 5, 2025, with the next earnings report estimated for August 19, 2026.
2026-07-23 00:41:00
Accuray Incorporated (XEJ) released its Q1 2025 earnings report, showing an actual EPS of -€0.04, which beat the consensus EPS of -€0.04. The company's revenue for the quarter was €88.94M, surpassing the expected €85.44M, despite a slight year-over-year revenue decrease of 2.26%. The next earnings report is estimated for August 19, 2026.
2026-07-11 13:44:47
Accuray Incorporated has voluntarily recalled 48 units of its Cyberknife Treatment Deliver System equipped with the Xchange Robotic Collimator Changer. The recall, classified as Class II, was initiated due to a software issue where a collimator might not fully dock, potentially falling if motion is initiated in the treatment room. The recalled units were distributed worldwide, and the firm began the recall process on June 16, 2026.
2026-07-07 19:39:51
Neuberger Berman Group LLC has reported a beneficial ownership of 6,073,663 shares, representing 5.1% of Accuray Inc (NASDAQ: ARAY) common stock, as of June 30, 2026. The filing indicates shared voting power of 4,270,281 shares and shared dispositive power of 6,073,663 shares, with holdings aggregated across various affiliated entities in fiduciary capacities. Neuberger Berman entities disclaim direct economic interest in these client holdings,
